Established Compliance Committees in European Direct Markets
Pregnant, nursing mothers, individuals with a known medical condition, and individuals using prescription drugs or over-the-counter medications should consult a healthcare professional before using this or any dietary supplement
METHODS: In this double-blind trial, we enrolled 1961 adults with a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or greater (27 in persons with 1 weight-related coexisting condition), who did not have diabetes, and randomly assigned them, in a 2:1 ratio, to 68 weeks of treatment with once-weekly subcutaneous semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention
In simple terms, it "weighs" the peptide
Inflammatory Bowel Disease 17:2318-2325, 2011
The trial ended after 70 weeks for patients who did not qualify as having pre-diabetes (i.e., their blood glucose levels were higher than normal but did not require medication)